Abbkine Scientific Company Limited, a Chinese-based research company has announced the addition of a new member of its antibody family, the Peroxiredoxin 1 Monoclonal Antibody. Also known as the PRDX1 antibody, the Peroxiredoxin-1 antibody is designed to make the process of investigation and research easier for scientists, helping to yield more results.
The antibody is formulated using the PRDX1, a substance that encodes a part of the peroxiredoxin family of antioxidant enzymes that reduce alkyl hydroperoxides and hydrogen peroxide. Peroxiredoxin 1 has also been identified to function as an antioxidant protection in cells, contributing to the antiviral activity of CD8(+) T-cells.
The product is a Proliferation-associated gene protein antibody, helping to fight possible development or progression of cancer. Available in liquid solution, the antibody has human, mouse and rat reactivity, with applications including IF, IHC-p, and WB.
The optimal working dilutions of the monoclonal antibody can be determined experimentally by the research or investigator as the case may be. However, the suggested starting dilutions are WB: 1:1000-3000, IF: 1:100-200.
The antibody was made using state-of-the-art technology as it has been affinity-purified from mouse ascites by affinity-chromatography using specific immunogen.
The product can remain stable for one year if stored under the right condition at -20°C. Abbkine has declared that the product is solely for research purpose and should not be used in human or for diagnostic purposes.
About Abbkine Scientific Co. Ltd
Abbkine Scientific is a scienitific research company originally established in California, USA in 2012 before moving its headquarters to China due to increasing demand for its products from Asia Pacific. The company through the combination of China’s manufacturing engineering and cost advantages and cutting edge technology from United States has been able to provide state-of-the-art scientific research solutions that include high quality assay kits, recombinant proteins, and antibodies.
没有评论:
发表评论